Search
for
Sort by
Research 301–330 of 873
- Epidermis-specific ablation of claudin-1 in adult mice demonstrates the essential role of a tight junction barrier in skin homeostasis
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- LB1019 The early region of trichodysplasia spinulosa polyomavirus drives proliferation, altered differentiation, and ectopic expression of hair follicle differentiation markers in interfollicular tail epidermis
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- Defining the hair follicle stem cell (Part I)
- Forensic approach in cases of anabolic-androgenic steroid abuse and cardiovascular mortality: insights from autopsy, histopathology, immunohistochemistry and toxicology
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Clinical Case Notes. Tamoxifen optic neuropathy
- Tamoxifen-Induced Total Alopecia
- Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography
- Tamoxifen-Induced Female Androgenetic Alopecia in a Patient with Breast Cancer
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Female pattern hair loss possibly caused by tamoxifen: Androgen receptor expression in the outer root sheath in the affected area
- Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines
- Nutraceuticals Known To Promote Hair Growth Do Not Interfere With The Inhibitory Action of Tamoxifen In MCF7, T47D And BT483 Breast Cancer Cell Lines
- Nutraceuticals Known to Promote Hair Growth Do not Interfere with the Inhibitory Action of Tamoxifen in MCF7, T47D and BT483 Breast Cancer Cell Lines
- LB822 Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in breast cancer cells
- Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
- The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue
- Effects of cyproterone and tamoxifen upon the hair waves in mice.
- Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Treatment options for polycystic ovary syndrome
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Alopecia With Endocrine Therapies in Patients With Cancer
- Clinical Case Notes. Intraorbital ophthalmic artery aneurysms